IE
RGNX icon

Israel Englander’s Regenxbio RGNX Stock Holding History

Israel Englander’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,000
Closed -$680K – 6425
2020
Q4 		$680K Buy
+15,000
New +$524K ﹤0.01% 3977

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Israel Englander's RGNX Position: Q2 2026 in Review

Israel Englander increased its Regenxbio (RGNX) stake by 69% in Q2 2026, buying an estimated $1.62M and bringing the position to 480,762 shares worth $5.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2852.

Israel Englander first reported a position in RGNX in Q3 2015 and has held it in 37 quarters since. The position peaked at $14.3M in Q1 2017. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Israel Englander held 480,762 shares of Regenxbio worth $5.76M as of Q2 2026.
  • Israel Englander bought 195,588 Regenxbio shares in Q2 2026, an estimated $1.62M.
  • Regenxbio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2852 holding.
  • Israel Englander first reported a position in Regenxbio in Q3 2015 and has held it in 37 quarters since.
  • Israel Englander's Regenxbio position peaked at $14.3M in Q1 2017.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.